SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.88+1.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: D Edwards who wrote (404)12/7/1997 6:17:00 PM
From: BigKNY3  Read Replies (2) of 9523
 
Dave: A major advantage of PFE is the size of its current product portfolio and future pipeline. Even if something happened to one of its products, PFE can recover (remember Tenidap?). I can never recall PFE getting particularly excited about an approval in the UK.

I have eliminated all one-product companies from my portfolio and concentrate on quality growth companies such as PFE, MSFT, and INTC. At times, one product companies may be fun to own but the risks and volatility always seem to outweigh the benefits. Give me a slow and steady 82% YTD growth like PFE!

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext